Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. (Q46099944)
Jump to navigation
Jump to search
scientific article published in March 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. |
scientific article published in March 2002 |
Statements
1 reference
Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059. (English)
1 reference
H Clifford Lane
1 reference
Donald I Abrams
1 reference
Judith D Bebchuk
1 reference
Eileen T Denning
1 reference
Richard T Davey
1 reference
Lawrence Fox
1 reference
James Sampson
1 reference
Rita Verheggen
1 reference
Douglas Zeh
1 reference
Norman P Markowitz
1 reference
Terry Beirn Community Programs for Clinical Research on AIDS
1 reference
1 March 2002
1 reference
29
1 reference
3
1 reference
221-231
1 reference